bosentan anhydrous has been researched along with desoxycorticosterone in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (72.73) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Larivière, R; Schiffrin, EL; Sventek, P; Thibault, G | 1 |
| Larivière, R; Li, JS; Schiffrin, EL | 1 |
| Li, JS; Reudelhuber, T; Schiffrin, EL; Sventek, P; Turgeon, A | 1 |
| Clozel, JP; Clozel, M; Gonzales, MF; Hess, P; Heudes, D; Karam, H; Löffler, BM | 1 |
| Doucet, J; Gonzalez, W; Michel, JB | 1 |
| Li, JS; Schiffrin, EL; Schürch, W | 1 |
| Clozel, JP; Clozel, M; Gonzales, MF; Heudes, D; Karam, H; Löffler, BM | 1 |
| Gopalakrishnan, V; McNeill, JR; Yu, M | 2 |
| Gopalakrishnan, V; McNeill, JR; Wilson, TW; Yu, M | 1 |
11 other study(ies) available for bosentan anhydrous and desoxycorticosterone
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Endothelin-1 expression in blood vessels of DOCA-salt hypertensive rats treated with the combined ETA/ETB endothelin receptor antagonist bosentan.
Topics: Animals; Base Sequence; Blood Pressure; Blood Vessels; Blotting, Northern; Body Weight; Bosentan; Desoxycorticosterone; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Hypertension; Male; Molecular Sequence Data; Polymerase Chain Reaction; Protein Precursors; Rats; Rats, Sprague-Dawley; RNA Probes; RNA-Directed DNA Polymerase; Sulfonamides | 1995 |
Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy.
Topics: Acetylcholine; Animals; Arteries; Bosentan; Desoxycorticosterone; Endothelin Receptor Antagonists; Endothelins; Hypertension; Hypertrophy; Male; Rats; Rats, Sprague-Dawley; Renin; Sodium Chloride; Sulfonamides; Vasoconstriction | 1994 |
Antihypertensive effect of an endothelin receptor antagonist in DOCA-salt spontaneously hypertensive rats.
Topics: Animals; Aorta; Base Sequence; Blood Pressure; Blotting, Northern; Bosentan; Desoxycorticosterone; Endothelin Receptor Antagonists; Endothelins; Hypertension; Mesenteric Arteries; Molecular Sequence Data; Radioimmunoassay; Rats; Rats, Inbred SHR; Receptor, Endothelin A; Receptors, Endothelin; RNA, Messenger; Sulfonamides | 1995 |
Respective role of humoral factors and blood pressure in cardiac remodeling of DOCA hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Bosentan; Calcium Channel Blockers; Cardiomegaly; Collagen; Coronary Circulation; Desoxycorticosterone; Enalapril; Endothelin Receptor Antagonists; Fibrosis; Hypertension; Male; Mibefradil; Myocardium; Perfusion; Rats; Rats, Wistar; Sulfonamides; Tetrahydronaphthalenes | 1996 |
Endothelin antagonists in salt-dependent hypertension associated with renal insufficiency.
Topics: Animals; Blood Pressure; Bosentan; Desoxycorticosterone; Endothelins; Glomerular Filtration Rate; Hypertension; Peptides, Cyclic; Rats; Rats, Wistar; Renal Circulation; Renal Insufficiency; Sodium Chloride; Sulfonamides | 1996 |
Renal and vascular effects of chronic endothelin receptor antagonism in malignant hypertensive rats.
Topics: Animals; Arteries; Blood Pressure; Bosentan; Desoxycorticosterone; Endothelin Receptor Antagonists; Endothelin-1; Hemodynamics; Hypertension, Malignant; Hypertrophy; Kidney; Organ Size; Rats; Rats, Inbred SHR; Renin; Sulfonamides | 1996 |
Respective role of humoral factors and blood pressure in aortic remodeling of DOCA hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Benzimidazoles; Blood Pressure; Bosentan; Calcium Channel Blockers; Desoxycorticosterone; Enalapril; Endothelin Receptor Antagonists; Endothelins; Hypertension, Renovascular; Male; Mibefradil; Rats; Rats, Wistar; Sulfonamides; Tetrahydronaphthalenes; Tunica Media | 1996 |
Total peripheral conductance mediates antihypertensive effect of nonpeptide mixed endothelin receptor antagonist in deoxycorticosterone acetate-salt hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Bosentan; Cardiac Output; Desoxycorticosterone; Endothelin Receptor Antagonists; Hypertension; Infusions, Intravenous; Male; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Sulfonamides; Vascular Resistance | 1999 |
Role of endothelin and vasopressin in DOCA-salt hypertension.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Bosentan; Cardiac Output; Desoxycorticosterone; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Hypertension; Injections, Intravenous; Male; Rats; Rats, Sprague-Dawley; Sulfonamides; Time Factors; Vascular Resistance; Vasopressins | 2001 |
Endothelin antagonist reduces hemodynamic responses to vasopressin in DOCA-salt hypertension.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Arginine Vasopressin; Blood Pressure; Bosentan; Cardiac Output; Desoxycorticosterone; Endothelin-1; Hemodynamics; Hypertension; Male; Rats; Rats, Sprague-Dawley; Sodium Chloride; Sulfonamides; Vascular Resistance; Vasoconstrictor Agents | 2001 |